FDA Enforcement Class II Ongoing

NxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C0468

Recall: Z-0043-2025 · Reported October 16, 2024

Enforcement

Recall Number
Z-0043-2025
Event ID
95377
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Luminex Molecular Diagnostics Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
October 16, 2024
Initiation Date
September 5, 2024
Classification Date
October 9, 2024
Address
439 University Ave Suite 900, Toronto, N/A, Canada

Description

NxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C0468

Reason

Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially result in hMPV false positives.

Code Info

Lot/Expiration: IK056C-0033/ 9/30/2024, IK056C-0034/ 10/31/2024, IK056C-0035/ 10/31/2024, IK056C-0036/ 12/31/2024, IK056C-0037/ 12/31/2024, IK056C-0038/ 12/31/2024, IK056C-0039/ 1/31/2025

Distribution

U Nationwide distribution in the states of OH, CA, NC, WI, TN, TX, MI, NY, MO, FL, MA, NJ, PA, VA, AZ, IL, OK, CO, MN.

Quantity

613